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Abstract
Objective: To compare the eficacy and safety of 4 mg of ondansetron vs. 4 mg of nalbuphine for 
the treatment of neuraxial morphine-induced pruritus, in patients at the “Dr. José Eleuterio 
González” University Hospital from September 2012 to August 2013. 
Material and methods: A controlled, prospective, randomized study of 28 patients (14 per 
group) receiving neuraxial morphine analgesia was conducted, which was registered and appro-
ved by the ethics Committee of the Institution and patients agreed to participate in the study 
under informed consent. The results were segmented and contrasted (according to drug) by 
hypothesis testing; the association was determined by X2 with a 95% conidence interval (CI). 
Results: Pruritus was effectively resolved in both groups and no signiicant difference was found 
in the rest of the variables. An increase in the visual analogue scale (eVA) was observed at 6 
and 12 hours for the ondansetron group, which was statistically signiicant (p≤0.05), however 
both groups had an eVA of less than 3. 
Conclusions: When comparing the eficacy and safety of ondansetron 4 mg vs. nalbuphine 4 mg 
for the treatment of neuraxial morphine induced pruritus, the only signiicant difference found 
was the mean eVA at 6 and 12 hours, favoring the ondansetron group. However, both groups 
scored less than 3 on the eVA. Therefore, we consider that both treatments are effective and 
safe in the treatment of pruritus caused by neuraxial morphine.
1665-5796 © 2014 revista Medicina Universitaria. Facultad de Medicina UANL. Publicado por elsevier México. Todos 
los derechos reservados.
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Introduction 
Neuraxial administration of opioids provides excellent post-
operative analgesia, however its use is associated with a 
high incidence of side effects such as pruritus (itching), nau-
sea, vomiting, urinary retention and respiratory depres-
sion.1-4 
The term “pruritus” or “prurire” is an unpleasant sensa-
tion which causes the desire to scratch and varies in intensi-
ty. It is one of the most common side effects in epidural 
and/or intrathecal administration of opiates with an inci-
dence of approximately 60%, compared to 2%-10% of the pa-
tients treated systematically; thus, its incidence depends 
on the route of administration. This symptom is common in 
postpartum women. The most affected areas are those in-
nervated by the trigeminal, probably due to their higher 
number of opiate receptors in the spinal nucleus of the tri-
geminal nerve, causing patients to scratch their nose and 
the upper part of the face. There are several chemical me-
diators responsible for pruritus (histamine, serotonin, cyto-
kines, growth factors, prostaglandins, etc.).1-6,7
The cause of pruritus induced by the administration of 
neuraxial opiates is uncertain; nevertheless there are 3 
theories that may explain its origin. The 1st theory is asso-
ciated with the release of peripheral histamine caused by 
the administration of morphine; however, this theory has 
not been proven because the antihistamines were ineffecti-
ve in the treatment of pruritus caused by intrathecal mor-
phine. The 2nd theory involves μ-opioid receptors responsible 
for pain modulation and some side effects, especially pruri-
tus, nausea and vomiting, in the central nervous system ac-
tivated by morphine. This explains the antipruritic effects 
of naloxone and nalbuphine, both μ-antagonists.2,3,8 A 3rd 
theory is that pruritus induced by the administration of neu-
raxial opiates could be related to the excitatory effects of 
opioids over nociceptive and non-nociceptive neurons in the 
anterior and posterior horns. It has been reported that mor-
phine can activate serotonin receptors due to an indepen-
dent mechanism of the opioid receptors. Therefore, the 
direct irritation of the serotonin type-3 receptors in the spi-
nal cord, dorsal horn and bone marrow caused by the admi-
nistration of morphine is possibly the mechanism of 
pruritus.8 
In light of the above, a great variety of medications has 
been evaluated for the prevention and treatment of pruri-
tus induced by opioids, including antihistamines, 5-hydroxy-
tryptamine (5-HT3) antagonists, opioid receptor antagonists, 
non-steroidal anti-inlammatory drugs, propofol and drope-
ridol. None of them have had satisfactory results.1-3,9,10 Na-
loxone and nalbuphine are opioid antagonist drugs used for 
this purpose and proven to be effective by different authors 
as a therapeutic agent for the reversion of pruritus induced 
by the neuraxial administration of opioids. Nalbuphine is an 
agonist-antagonist opioid and its analgesic effect and pro-
bable antipruritic effect are mediated by its action in mu 
and kappa receptors.4,10,11 These medications could play a 
role in the treatment of pruritus, with a disadvantage, 
however, because its preventive administration reduces its 
analgesic efictiveness.3
Other medications used for the treatment of pruritus are the 
5-HT3 receptor antagonists. Ondansetron, for example, which 
has been successfully used in the treatment of neuraxial 
morphine-induced pruritus, because of its antipruritic 
effect and its role in the nociception, contrary to the use of 
opioid receptor antagonists.
The objective of our study was to compare the eficiency 
and safety of 4 mg of nalbuphine vs. 4 mg of ondansetron, 
for the treatment of neuraxial morphine-induced pruritus as 
post-operative analgesic in patients programed for elective 
surgery.
Material and methods 
After the approval of the ethics Committee and the re-
search Committee of the School of Medicine at the “Dr. José 
Eleuterio González” University Hospital of Universidad Au-
tónoma de Nuevo León (UANL, by its Spanish acronym), we 
conducted a study from September 2012 to August 2013, 
a controlled, prospective, comparative and randomized cli-
nical trial with 28 patients programed for surgery under 
neuraxial anesthesia and receiving epidural or subarachnoid 
morphine analgesia. Patients who agreed to participate in 
the trial had to sign an informed consent and meet the fo-
llowing criteria: ASA I and II patients, undergoing surgery 
with neuraxial anesthesia and presenting pruritus seconda- 
ry to the administration of epidural or subarachnoid morphi-
ne, either male and female between 18 and 50 years old, a 
signed consent form, neurologically intact and able to as-
sess pain using the visual analogue scale (eVA). We excluded 
those patients with neurological alterations of the state of 
consciousness, patients with a history of allergy to nalbuphi-
ne and ondansetron and local anesthetics, patients under 18 
and older than 50 years of age, patients who did not accept 
this type of administration of analgesia and patients with a 
dermatological condition.
All patients were administered intravenous 10 mg of 
metoclopramide and 50 mg of ranitidine intravenously  as 
pre-anesthetic medications. We monitored all patients with 
a continuous electrocardiogram, pulse oximetry and non-
invasive blood pressure every 5 minutes during the whole 
procedure; they received oxygen at 5 L per minute through 
a face mask. Subsequently, we applied a neuraxal block 
(epidural, subarachnoid or both), once applied we adminis-
tered local anesthetic and 100 mcg of morphine (subarach-
noid or epidural) using the following formula (-0.01 * age + 
1.85 mg). We assessed the presence of pruritus at 30 minutes 
and 2, 6, 12 and 24 hours after morphine administration; the 
patients who presented pruritus were divided into 2 groups: 
group “O” (ondansetron) and group “N” (nalbuphine). We ad-
ministered 4 mg of the corresponding drug to each group and 
we registered the presence of pruritus, nausea, vomiting, 
ramsay sedation scale, blood pressure, respiratory frequency 
and pain using the eVA scale from 0 to 10 (0 = no pain and 10 
= intense pain) and the use of rescue medication.
The obtained results were gathered in a database develo-
ped using Microsoft excel® and analyzed using IBM SPSS® Sta-
tistics v. 20.0. We obtained traditional descriptive statistics, 
as well as observed frequencies in accordance with the 
administered medication (ondansetron and nalbuphine) 
through median and proportion hypothesis-testing, as the 
case may be for each type of variable (quantitative and qua-
litative respectively) with a conidence interval (CI) of 95%. 
Statistical association was determined using X2 with a 95% CI.
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Results
A total of 28 patients were studied, randomly distributed 
into 2 groups of 14 patients each. The median age in the O 
group was 26.9 and 28.7 for the N group. All of the patients 
were female, programmed for a C-section. We performed 
21 epidural blocks, 6 subarachnoid blocks and one combi- 
ned subarachnoid-epidural technique. 
In both groups mild pruritus (itching) occurred in 15 pa-
tients during the first 12 hours, moderate pruritus in 13 
patients between the 2nd and 6th hour subsequent to the ad-
ministration of morphine; this was resolved in all patients. 
We did not ind a signiicant difference between groups (Ta-
ble 1).
The presence of pain was assessed according to the eVA, a 
signiicant difference was found (p≤0.05) at 6 and 12 hours 
in favor of the O group. The average score in the eVA pain 
scale was less than 3, hence we did not administer any res-
cue medications (Fig. 1). When we analyzed the variables 
(blood pressure, ramsay, respiratory frequency, nausea and 
vomiting), we did not ind a statistically signiicant differen-
ce (p>0.05) (Tables 2, 3 and 4). 
Discussion
Pruritus incidence subsequent to neuraxial morphine admi-
nistration is approximately 60%, compared to 2%-10% of the 
patients treated systematically. Thus, its incidence depends 
on the route of administration. This symptom is common in 
postpartum women. The most affected areas are those in-
nervated by the trigeminal, probably due to their higher 
number of opiate receptors in the spinal nucleus of the tri-
geminal nerve, causing patients to scratch their nose and 
the upper part of the face. There are several chemical me-
diators responsible for pruritus (histamine, serotonin, cyto-
kines, growth factors, prostaglandins, etc.).1-3,5-7
There is evidence that opioids and the serotonergic sys-
tem interact closely in the central nervous system. One 
example is ondansetron, a 5-HT3 antagonist with an anti-
pruritic effect. In 1995 Fan reported that morphine can ac-
tivate serotonin type-3 receptors in the spinal cord dorsal 
horn and bone marrow and that could possibly be the me-
chanism causing pruritus.1-3,9,10,12,13
Since 1999 there have been studies comparing ondansetron’s 
effectiveness in the treatment of epidural morphine-induced 
pruritus, where its effectiveness has been demonstrated.8,12-15 
In our study, pruritus occurred more frequently between 2 and 
4 hours in both groups. These results are consistent with those 
reported in medical literature.16 Pruritus caused by opioids 
can be extremely dificult to manage and approximately 10%-
15% of the patients showed no response to naloxone.17
In our study, pruritus was effectively treated in both 
groups and did not require the use of rescue medications.
We did not observe changes in the level of pain in the O 
group; however, there was an increment in the eVA scale at 
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Figure 1 Analysis of visual analogue scale average by time.
Table 1 Analysis of pruritus average by time.
Time 30 minutes 2 hours 6 hours 12 hours 24 hours
Average pruritus, O group 1.07 1.79 1.43 1.00 1.00
Average pruritus, N group 1.36 1.64 1.36 1.07 0.93
O group: ondansetron group; N group: nalbuphine. 
N=28 patients (14 per group). 
Source: Standardized instrument.
Table 2 Comparative analysis of ramsey by time.
Time 30 minutes 2 hours 6 hours 12 hours 24 hours
ramsey average, O group 1.93 2.07 2.00 2.07 2.00
ramsey average, N group 2.00 2.14 2.29 1.93 1.93
O group: ondansetron group; N group: nalbuphine. 
N=28 patients (14 per group). 
Source: Standardized instrument.
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6 and 12 hours in the N group, probably because of its ago-
nist-antagonist effect of the mu, kappa and delta receptors. 
Nevertheless, both groups had an eVA score lower than 3. 
We did not ind differences in sedation levels in any of the 
groups during the period of study.
The presence of nausea and vomiting is common after the 
administration of opioids.18 Nausea occurs within the irst 4 
hours subsequent to the administration and vomiting occurs 
right after this. High dosages of opioids can cause arteriolar 
and venous dilatation, a decrease in peripheral vascular re-
sistance and baroreceptors relex inhibition, which can cau-
se postural hypotension. Opioids cause dose-dependent 
bradycardia, probably because of sympatholytic and paras-
ympatholytic mechanisms. There were no statistically signi-
icant hemodynamic changes during the entire trial. Even 
though opioids cause dose-dependent respiratory depres-
sion, there were no alterations in respiratory frequency in 
the patients with nalbuphine.9 
This study shows that nalbuphine was well-tolerated, only 
displaying changes in the level of analgesia (eVA 3), which 
did not require rescue medication, unlike ondansetron, 
which did not display changes in analgesia levels and no side 
effects were reported. However, both medications proved 
to be safe and eficient for the treatment of neuraxial mor-
phine-induced pruritus.
Conclusions 
When comparing the eficacy and safety of 4 mg of ondanse-
tron vs. 4 mg of nalbuphine for the treatment of neuraxial 
morphine-induced pruritus, the only signiicant difference 
found was the mean eVA at 6 and 12 hours, favoring the on-
dansetron group. However, both groups had an eVA of less 
than 3. Based on the obtained results we reject the null 
hypothesis, which states that the administration of intrave-
nous ondansetron at 4 mg is not as effective as the adminis-
tration of nalbuphine at 4 mg in the treatment of neuraxial 
morphine-induced pruritus. 
Therefore, we consider that both treatments are effecti-
ve and safe in the treatment of pruritus caused by neuraxial 
morphine.
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